Skip to main content

Table 2 Slope of risperidone utilisation between the four European countries after generic risperidone became available (month 0)

From: Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

Country

Slopea

Belgium

−0.165

Ireland

−0.143

Scotland

−0.075

Sweden

−0.194

  1. aA slope of −0.165 = a drop of 0.165%/month in the utilisation of risperidone as a percenage of all selected atypical antipsychotics following the introduction of generic risperidone.
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us